Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | SGC0946 |
Trade Name | |
Synonyms | |
Drug Descriptions |
SGC0946 inhibits DOT1L, resulting in reduced viability of leukemia cells with MLL fusions (PMID: 23250418, PMID: 28209620). |
DrugClasses | DOT1L Inhibitor 3 |
CAS Registry Number | 1561178-17-3 |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
I-BET151 + SGC0946 | I-BET151 SGC0946 | 1 | 0 |
SGC0946 | SGC0946 | 0 | 0 |